Physician profile
David P Huberty
NPI 1518992296
$36,945.93
in general payments reported to CMS, 2019-2025
21 companies · $431 in 2025
The $431 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $7,632 · 2021: $14K · 2022: $153 · 2023: $155 · 2024: $53.32 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $30,400.46 | 2019-2023 | Arthroplasty Implants Anatomic Total Shoulder Eclipse |
| Steelhead Surgical INC | $5,262.77 | 2019-2021 | |
| Left Coast Surgical INC | $398.83 | 2025 | |
| Dynasplint Systems INC. | $181.25 | 2019 | |
| Smith+Nephew, INC. | $143.54 | 2020-2025 | Evos, Pico 14, Renasys Touch |
| Heraeus Medical, LLC. | $93.39 | 2019 | |
| Sanofi-Aventis U.S. LLC | $71.03 | 2019-2020 | |
| Djo, LLC | $58.78 | 2019-2023 | Cmf |
| Ethicon US, LLC | $53.13 | 2020-2023 | Dermabond Prineo |
| Pacira Therapeutics, INC. | $49.71 | 2019 | |
| Zimmer Biomet Holdings, INC. | $31.96 | 2019-2024 | Tapestry |
| Endo Pharmaceuticals INC. | $29.92 | 2021-2022 | |
| Medtronic Vascular, INC. | $27.39 | 2019 | |
| Anika Therapeutics, INC. | $26.57 | 2022 | |
| Abbott Laboratories | $24.36 | 2023 | Eterna |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $18.03 | 2019 | |
| Bioventus LLC | $17.78 | 2020 | |
| Orthogenrx INC. | $15.73 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.73 | 2025 | Exparel, Zilretta, Iovera |
| Orthofix Medical, INC. | $13.86 | 2020 | |
| Molnlycke Health Care US, LLC | $11.71 | 2024 | Avance, Mepilex Border Post-Op Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Huberty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.